AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$17.44
−2.41%Leverage
- Debt / equity
- 84.54x
- Net debt / equity
- 80.67x
- Debt / assets
- 0.74x
- Debt / EBITDA
- 4.28x
- Net debt / EBITDA
- 4.08x
Liquidity & coverage
- Current ratio
- 2.20x
- Quick ratio
- 1.44x
- Cash ratio
- 0.14x
- Interest coverage
- 1.77x
- EBITDA / interest
- 2.87x
- Working capital
- $1.1B
Cash & dividend
- FCF / debt
- 0.03x
- Cash flow / debt
- 0.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026